Literature DB >> 21521319

What medical options should be considered for the treatment of primary hyperparathyroidism?

Mara J Horwitz1.   

Abstract

Primary hyperparathyroidism (PHPT) is a common, often asymptomatic, endocrine disorder characterized by hypercalcaemia in the face of a nonsuppressed parathyroid hormone (PTH) level. For those with symptomatic disease or who meet surgical criteria, parathyroidectomy is the treatment of choice. However, those patients who do not meet surgical criteria or who cannot undergo or refuse surgery must be managed medically. Medical management of PHPT involves continual assessment to determine who will benefit from surgical intervention, replacement of vitamin D, treatment of parathyroid bone disease and management of hypercalcaemia and renal stone disease.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521319     DOI: 10.1111/j.1365-2265.2011.04050.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

1.  Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism.

Authors:  Symeon Tournis; Eleni Fakidari; Ismene Dontas; Chrysoula Liakou; Julia Antoniou; Antonis Galanos; Helen Marketou; Konstantinos Makris; Katerina Katsalira; George Trovas; George P Lyritis; Nikolaos Papaioannou
Journal:  J Bone Miner Metab       Date:  2013-05-23       Impact factor: 2.626

Review 2.  Parathyroidectomy: is vitamin D a player for a good outcome?

Authors:  M Carsote; D N Paduraru; A E Nica; A Valea
Journal:  J Med Life       Date:  2016 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.